BEC Glucosamine Sulfate
Natural health product licensed in Canada
- Licence holder
- Biotechnologies Explorer Canada Inc.
- NPN or DIN-HM
- 80000211
- Status
- Active licence
- Licence date
- 14 December 2004
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- (M) non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Capsule | 3 Tous les jours |
Uses authorised in Canada
Contribue à soulager les symptômes ostéoarthritiques. Joue un rôle dans le maintien du cartilage. Protège contre la détérioration du cartilage résultant des maladies. efficace dans la réduction de la douleur articulaire. chroniques des articulations.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consulter un fournisseur de soins de santé avant l¿utilisation si vous souffrez du diabète. Ranger dans un endroit frais et sec.
- Contre-indications
À éviter en cas d¿allergie aux mollusques. Ne pas utiliser en cas de grossesse ou d¿allaitement.
Source
Official Health Canada record, licence 80000211
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.